329 related articles for article (PubMed ID: 34895470)
1. Pharmacotherapy for adults with overweight and obesity: a systematic review and network meta-analysis of randomised controlled trials.
Shi Q; Wang Y; Hao Q; Vandvik PO; Guyatt G; Li J; Chen Z; Xu S; Shen Y; Ge L; Sun F; Li L; Yu J; Nong K; Zou X; Zhu S; Wang C; Zhang S; Qiao Z; Jian Z; Li Y; Zhang X; Chen K; Qu F; Wu Y; He Y; Tian H; Li S
Lancet; 2022 Jan; 399(10321):259-269. PubMed ID: 34895470
[TBL] [Abstract][Full Text] [Related]
2. Pharmacotherapy for adults with overweight and obesity: a systematic review and network meta-analysis of randomised controlled trials.
Shi Q; Wang Y; Hao Q; Vandvik PO; Guyatt G; Li J; Chen Z; Xu S; Shen Y; Ge L; Sun F; Li L; Yu J; Nong K; Zou X; Zhu S; Wang C; Zhang S; Qiao Z; Jian Z; Li Y; Zhang X; Chen K; Qu F; Wu Y; He Y; Tian H; Li S
Lancet; 2024 Apr; 403(10434):e21-e31. PubMed ID: 38582569
[TBL] [Abstract][Full Text] [Related]
3. Clinical outcomes associated with drugs for obesity and overweight: A systematic review and network meta-analysis of randomized controlled trials.
Iannone A; Natale P; Palmer SC; Nicolucci A; Rendina M; Giorgino F; Laviola L; Di Leo A; Strippoli GFM
Diabetes Obes Metab; 2023 Sep; 25(9):2535-2544. PubMed ID: 37254688
[TBL] [Abstract][Full Text] [Related]
4. Association of Pharmacological Treatments for Obesity With Weight Loss and Adverse Events: A Systematic Review and Meta-analysis.
Khera R; Murad MH; Chandar AK; Dulai PS; Wang Z; Prokop LJ; Loomba R; Camilleri M; Singh S
JAMA; 2016 Jun; 315(22):2424-34. PubMed ID: 27299618
[TBL] [Abstract][Full Text] [Related]
5. Long-term effects of weight-reducing drugs in people with hypertension.
Siebenhofer A; Winterholer S; Jeitler K; Horvath K; Berghold A; Krenn C; Semlitsch T
Cochrane Database Syst Rev; 2021 Jan; 1(1):CD007654. PubMed ID: 33454957
[TBL] [Abstract][Full Text] [Related]
6. Effects of low-dose, controlled-release, phentermine plus topiramate combination on weight and associated comorbidities in overweight and obese adults (CONQUER): a randomised, placebo-controlled, phase 3 trial.
Gadde KM; Allison DB; Ryan DH; Peterson CA; Troupin B; Schwiers ML; Day WW
Lancet; 2011 Apr; 377(9774):1341-52. PubMed ID: 21481449
[TBL] [Abstract][Full Text] [Related]
7. Long-term effects of weight-reducing drugs in people with hypertension.
Siebenhofer A; Jeitler K; Horvath K; Berghold A; Posch N; Meschik J; Semlitsch T
Cochrane Database Syst Rev; 2016 Mar; 3():CD007654. PubMed ID: 26934640
[TBL] [Abstract][Full Text] [Related]
8. The Weight-loss Effect of GLP-1RAs Glucagon-Like Peptide-1 Receptor Agonists in Non-diabetic Individuals with Overweight or Obesity: A Systematic Review with Meta-Analysis and Trial Sequential Analysis of Randomized Controlled Trials.
Liu Y; Ruan B; Jiang H; Le S; Liu Y; Ao X; Huang Y; Shi X; Xue R; Fu X; Wang S
Am J Clin Nutr; 2023 Sep; 118(3):614-626. PubMed ID: 37661106
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and Safety of Phentermine/Topiramate in Adults with Overweight or Obesity: A Systematic Review and Meta-Analysis.
Lei XG; Ruan JQ; Lai C; Sun Z; Yang X
Obesity (Silver Spring); 2021 Jun; 29(6):985-994. PubMed ID: 33864346
[TBL] [Abstract][Full Text] [Related]
10. Pharmacotherapy weight-loss interventions to prevent type 2 diabetes in overweight or obese adults and older adults: A protocol for systematic review and network meta-analysis.
Yang W; Wen J; Wu F; Zeng H; Guo B; Ge L
Medicine (Baltimore); 2021 Mar; 100(11):e24812. PubMed ID: 33725948
[TBL] [Abstract][Full Text] [Related]
11. Effect of naltrexone plus bupropion on weight loss in overweight and obese adults (COR-I): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial.
Greenway FL; Fujioka K; Plodkowski RA; Mudaliar S; Guttadauria M; Erickson J; Kim DD; Dunayevich E;
Lancet; 2010 Aug; 376(9741):595-605. PubMed ID: 20673995
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of GLP-1 receptor agonists versus SGLT-2 inhibitors in overweight/obese patients with or without diabetes mellitus: a systematic review and network meta-analysis.
Ma H; Lin YH; Dai LZ; Lin CS; Huang Y; Liu SY
BMJ Open; 2023 Mar; 13(3):e061807. PubMed ID: 36882248
[TBL] [Abstract][Full Text] [Related]
13. Pharmacotherapy in obesity: a systematic review and meta-analysis of randomized controlled trials of anti-obesity drugs.
Singh AK; Singh R
Expert Rev Clin Pharmacol; 2020 Jan; 13(1):53-64. PubMed ID: 31770497
[No Abstract] [Full Text] [Related]
14. Drug interventions for the treatment of obesity in children and adolescents.
Mead E; Atkinson G; Richter B; Metzendorf MI; Baur L; Finer N; Corpeleijn E; O'Malley C; Ells LJ
Cochrane Database Syst Rev; 2016 Nov; 11(11):CD012436. PubMed ID: 27899001
[TBL] [Abstract][Full Text] [Related]
15. Benefits and harms of drug treatment for type 2 diabetes: systematic review and network meta-analysis of randomised controlled trials.
Shi Q; Nong K; Vandvik PO; Guyatt GH; Schnell O; Rydén L; Marx N; Brosius FC; Mustafa RA; Agarwal A; Zou X; Mao Y; Asadollahifar A; Chowdhury SR; Zhai C; Gupta S; Gao Y; Lima JP; Numata K; Qiao Z; Fan Q; Yang Q; Jin Y; Ge L; Yang Q; Zhu H; Yang F; Chen Z; Lu X; He S; Chen X; Lyu X; An X; Chen Y; Hao Q; Standl E; Siemieniuk R; Agoritsas T; Tian H; Li S
BMJ; 2023 Apr; 381():e074068. PubMed ID: 37024129
[TBL] [Abstract][Full Text] [Related]
16. Two-year sustained weight loss and metabolic benefits with controlled-release phentermine/topiramate in obese and overweight adults (SEQUEL): a randomized, placebo-controlled, phase 3 extension study.
Garvey WT; Ryan DH; Look M; Gadde KM; Allison DB; Peterson CA; Schwiers M; Day WW; Bowden CH
Am J Clin Nutr; 2012 Feb; 95(2):297-308. PubMed ID: 22158731
[TBL] [Abstract][Full Text] [Related]
17. Long-Term Efficacy and Safety of Anti-Obesity Treatment: Where Do We Stand?
Tak YJ; Lee SY
Curr Obes Rep; 2021 Mar; 10(1):14-30. PubMed ID: 33410104
[TBL] [Abstract][Full Text] [Related]
18. AGA Clinical Practice Guideline on Pharmacological Interventions for Adults With Obesity.
Grunvald E; Shah R; Hernaez R; Chandar AK; Pickett-Blakely O; Teigen LM; Harindhanavudhi T; Sultan S; Singh S; Davitkov P;
Gastroenterology; 2022 Nov; 163(5):1198-1225. PubMed ID: 36273831
[TBL] [Abstract][Full Text] [Related]
19. Effects of glucagon-like peptide-1 receptor agonists on weight loss: systematic review and meta-analyses of randomised controlled trials.
Vilsbøll T; Christensen M; Junker AE; Knop FK; Gluud LL
BMJ; 2012 Jan; 344():d7771. PubMed ID: 22236411
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]